BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28552736)

  • 1. Analysis of Prognostic Factors, Survival Rates, and Treatment in Anaplastic Hemangiopericytoma.
    Zhang GJ; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2017 Aug; 104():795-801. PubMed ID: 28552736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Management and Adverse Factors for Recurrence and Long-Term Survival in Patients with Hemangiopericytoma.
    Zhang GJ; Wu Z; Zhang LW; Li D; Zhang JT
    World Neurosurg; 2017 Aug; 104():95-103. PubMed ID: 28502683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome and Prognostic Factors After Repeated Surgeries for Intracranial Hemangiopericytomas.
    Wang W; Zhang GJ; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2017 Nov; 107():495-505. PubMed ID: 28823664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma.
    Lee EJ; Kim JH; Park ES; Khang SK; Cho YH; Hong SH; Kim CJ
    J Neurooncol; 2016 Mar; 127(1):181-90. PubMed ID: 26721243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of recurrent intracranial hemangiopericytoma.
    Rutkowski MJ; Bloch O; Jian BJ; Chen C; Sughrue ME; Tihan T; Barani IJ; Berger MS; McDermott MW; Parsa AT
    J Clin Neurosci; 2011 Nov; 18(11):1500-4. PubMed ID: 21917462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.
    Jeon SH; Park SH; Kim JW; Park CK; Paek SH; Kim IH
    J Neurooncol; 2018 May; 137(3):567-573. PubMed ID: 29327171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal treatment and management strategies for intracranial hemangiopericytoma.
    Chen LF; Yang Y; Yu XG; Gui QP; Xu BN; Zhou DB
    J Clin Neurosci; 2015 Apr; 22(4):718-25. PubMed ID: 25744076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemangiopericytoma: long-term outcome revisited. Clinical article.
    Schiariti M; Goetz P; El-Maghraby H; Tailor J; Kitchen N
    J Neurosurg; 2011 Mar; 114(3):747-55. PubMed ID: 20672899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas.
    Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1333-9. PubMed ID: 18723295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial hemangiopericytoma--our experience in 30 years: a series of 43 cases and review of the literature.
    Melone AG; D'Elia A; Santoro F; Salvati M; Delfini R; Cantore G; Santoro A
    World Neurosurg; 2014; 81(3-4):556-62. PubMed ID: 24239740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors in Patients with Primary Hemangiopericytomas of the Central Nervous System: A Series of 103 Cases at a Single Institution.
    Zhu H; Duran D; Hua L; Tang H; Chen H; Zhong P; Zheng K; Wang Y; Che X; Bao W; Wang Y; Xie Q; Gong Y
    World Neurosurg; 2016 Jun; 90():414-419. PubMed ID: 26960287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemangiopericytoma: Radical resection remains the cornerstone of therapy.
    Ramakrishna R; Rostomily R; Sekhar L; Rockhill J; Ferreira M
    J Clin Neurosci; 2014 Apr; 21(4):612-5. PubMed ID: 24231562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors.
    Kim BS; Kim Y; Kong DS; Nam DH; Lee JI; Suh YL; Seol HJ
    J Neurosurg; 2018 Dec; 129(6):1384-1396. PubMed ID: 29372881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced rhabdomyosarcomatous transformation of a recurrent meningeal haemangiopericytoma.
    Leung GK; Lee WC; Nicholls JM
    Acta Neurochir (Wien); 2007 Nov; 149(11):1163-7; discussion 1167. PubMed ID: 17906967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
    Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
    Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic analysis of recurrent hemangiopericytoma in the central nervous system: a review of 46 cases.
    Tian R; Hao S; Hou Z; Bian L; Zhang Y; Wu W; Xu F; Li H; Liu B
    J Neurooncol; 2013 Oct; 115(1):53-9. PubMed ID: 23824534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis.
    Ghia AJ; Allen PK; Mahajan A; Penas-Prado M; McCutcheon IE; Brown PD
    Neurosurgery; 2013 Feb; 72(2):203-9. PubMed ID: 23149953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraspinal Dissemination and Local Recurrence of an Intracranial Hemangiopericytoma.
    Hayenga HN; Bishop AJ; Wardak Z; Sen C; Mickey B
    World Neurosurg; 2019 Mar; 123():68-75. PubMed ID: 30503286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery.
    Olson C; Yen CP; Schlesinger D; Sheehan J
    J Neurosurg; 2010 Jan; 112(1):133-9. PubMed ID: 19392594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality following treatment of intracranial hemangiopericytoma.
    Rutkowski MJ; Sughrue ME; Kane AJ; Aranda D; Mills SA; Barani IJ; Parsa AT
    J Neurosurg; 2010 Aug; 113(2):333-9. PubMed ID: 20367074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.